Showing results (231-240 of 271) with videos related to
Sort By:
Pageof 28
World Neurosurgery|June 1, 2017
Impact of Prehospital Transportation on Survival in Skiers and Snowboarders with Traumatic Brain InjuryHai Sun, Navdeep S Samra, Piyush Kalakoti, et al.Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|September 5, 2024
Outcomes of a Multidisciplinary Vascular Practice: 12-Month Amputation-Free Survival and Beyond in Patients With Chronic Limb-Threatening IschemiaRamkrishna A Patel, Brooke Fallon, Aaron Brandis, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 10, 2022
Defining the rate of nutritional and metabolic derangements after pancreatic resectionK L Percy, Y X Ooi, C B Nahm, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2016
A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experienceS M Schlichtemeier, T C Pang, N E Williams, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapyAsanka R Wijetunga, Terence C Chua, Christopher B Nahm, et al.Pancreas|February 4, 2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal AdenocarcinomaMalinda Itchins, Terence C Chua, Jennifer Arena, et al.Annals of Surgical Oncology|January 31, 2020
The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas CancerAndrew P Barbour, Jaswinder S Samra, Koroush S Haghighi, et al.Journal of the Indian Medical Association|January 30, 2004
Efficacy and safety of the first parenteral selective COX-2 inhibitor, parecoxib sodium, in adult patients with postoperative painS S Samra, Ravindra R Shah, S A Jagtap, et al.Genome Medicine|June 26, 2014
Returning individual research results for genome sequences of pancreatic cancerAmber L Johns, David K Miller, Skye H Simpson, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 12, 2025
Aiming for high quality of care for completed resections and improved margin status in pancreatic cancer surgeryAshika D Maharaj, Bronwyn Brown, Hamish Evans, et al.Pageof 28